First 90 Days: Page 2

  • Sosei Heptares CEO Chris Cargill
    Image attribution tooltip
    Permission granted by Sosei Heptares/Chris Cargill
    Image attribution tooltip
    Q&A // First 90 Days

    First 90 Days: Sosei Heptares’ Chris Cargill

    The company’s new CEO is looking to drive growth through collaboration and transparency.

    By Kim Ribbink • May 31, 2022
  • CEO of Syneos Health
    Image attribution tooltip

    Permission granted by Michelle Keefe. 

    Image attribution tooltip
    Q&A // First 90 Days

    First 90 Days: Syneos Health’s Michelle Keefe

    The newly minted CEO is leaning on her 30 years of experience leading high-performance teams to make her mark at Syneos.

    By • May 23, 2022
  • Image attribution tooltip
    Real Chemistry/PharmaVoice
    Image attribution tooltip
    Q&A

    Lessons from improv: Shankar Narayanan’s ‘yes, and’ approach to healthcare leadership

    Real Chemistry's CEO is bringing a unique set of skills to the role as he sets off on a company-wide listening tour.

    By • April 4, 2022
  • Image attribution tooltip
    Retrieved from PharmaVOICE on March 21, 2022
    Image attribution tooltip
    Q&A

    BioMarin’s new global head of advocacy is tackling the holy grail of patient engagement

    In her new role, Dr. Roz is keeping her patient-first approach.

    By • March 21, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Peter Anastasiou
    Image attribution tooltip
    Q&A // First 90 Days

    New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality

    Read what Capsida CEO Peter Anastasiou has planned for his new role. 

    By • Feb. 3, 2022